Abstract
(E)- and (Z)-3-Ferrocenylmethylidene-1,3-dihydro-2H-indol-2-ones 1 have been structurally modified in order to explore SAR against a range of kinases. Of note is the submicromolar to low micromolar inhibition of DYRK3 and 4 by a number of complexes. Screening using Xenopus embryos showed some of the compounds to have potent antiangiogenisis activity.
Original language | English |
---|---|
Pages (from-to) | 600-608 |
Journal | Metallomics |
Volume | 3 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2011 |